Synthetic nanoparticles for the delivery of CRISPR/Cas9 gene editing system: classification and biomedical applications

被引:5
|
作者
Zheng, Qi [1 ]
Wang, Weitao [2 ]
Zhou, Yuhang [1 ]
Mo, Jiayin [1 ]
Chang, Xinyue [1 ]
Zha, Zhengbao [2 ]
Zha, Lisha [1 ]
机构
[1] Anhui Agr Univ, Int Immunol Ctr, Hefei 230036, Peoples R China
[2] Hefei Univ Technol, Sch Food & Biol Engn, Hefei 230009, Peoples R China
基金
中国国家自然科学基金;
关键词
BLACK PHOSPHORUS NANOSHEETS; ADAPTIVE IMMUNE-SYSTEMS; CRISPR-CAS9; SYSTEM; DRUG-DELIVERY; MEDIATED DELIVERY; GRAPHENE OXIDE; CAS9; RIBONUCLEOPROTEIN; GOLD NANOPARTICLES; EFFICIENT DELIVERY; NONVIRAL DELIVERY;
D O I
10.1039/d3bm00788j
中图分类号
TB3 [工程材料学]; R318.08 [生物材料学];
学科分类号
0805 ; 080501 ; 080502 ;
摘要
Gene editing has great potential in biomedical research including disease diagnosis and treatment. Clustered regularly interspaced short palindromic repeats (CRISPR) is the most straightforward and cost-effective method. The efficient and precise delivery of CRISPR can impact the specificity and efficacy of gene editing. In recent years, synthetic nanoparticles have been discovered as effective CRISPR/Cas9 delivery vehicles. We categorized synthetic nanoparticles for CRISPR/Cas9 delivery and discribed their advantages and disadvantages. Further, the building blocks of different kinds of nanoparticles and their applications in cells/tissues, cancer and other diseases were described in detail. Finally, the challenges encountered in the clinical application of CRISPR/Cas9 delivery materials were discussed, and potential solutions were provided regarding efficiency and biosafety issues.
引用
收藏
页码:5361 / 5389
页数:30
相关论文
共 50 条
  • [41] Emerging CRISPR/Cas9 applications for T-cell gene editing
    Preece, Roland
    Georgiadis, Christos
    EMERGING TOPICS IN LIFE SCIENCES, 2019, 3 (03) : 261 - 275
  • [42] Therapeutic applications of CRISPR/Cas9 system in gene therapy
    Hasan Mollanoori
    Shahram Teimourian
    Biotechnology Letters, 2018, 40 : 907 - 914
  • [43] Brain and visceral gene editing of mucopolysaccharidosis I mice by nasal delivery of the CRISPR/Cas9 system
    Pimentel Vera, Luisa Natalia
    Schuh, Roselena Silvestri
    Silveira Fachel, Flavia Nathielly
    Poletto, Edina
    Piovesan, Eduarda
    Kubaski, Francyne
    Couto, Eduarda
    Brum, Bruna
    Rodrigues, Graziella
    Souza, Hallana
    Giugliani, Roberto
    Matte, Ursula
    Baldo, Guilherme
    Teixeira, Helder F.
    JOURNAL OF GENE MEDICINE, 2022, 24 (04):
  • [44] Therapeutic applications of CRISPR/Cas9 system in gene therapy
    Mollanoori, Hasan
    Teimourian, Shahram
    BIOTECHNOLOGY LETTERS, 2018, 40 (06) : 907 - 914
  • [45] Appropriate Delivery of the CRISPR/Cas9 System through the Nonlysosomal Route: Application for Therapeutic Gene Editing
    Yin, Hang
    Yuan, Xiaoling
    Luo, Lihua
    Lu, Yichao
    Qin, Bing
    Zhang, Junlei
    Shi, Yingying
    Zhu, Chunqi
    Yang, Jie
    Li, Xiang
    Jiang, Mengshi
    Luo, Zhenyu
    Shan, Xinyu
    Chen, Dawei
    You, Jian
    ADVANCED SCIENCE, 2020, 7 (14)
  • [46] Nanoparticles-Mediated CRISPR/Cas Gene Editing Delivery System
    Saw, Phei Er
    Cui, Guo-Hui
    Xu, Xiaoding
    CHEMMEDCHEM, 2022, 17 (09)
  • [47] Genome Editing in Cotton with the CRISPR/Cas9 System
    Gao, Wei
    Long, Lu
    Tian, Xinquan
    Xu, Fuchun
    Liu, Ji
    Singh, Prashant K.
    Botella, Jose R.
    Song, Chunpeng
    FRONTIERS IN PLANT SCIENCE, 2017, 8
  • [48] Delivery strategies of the CRISPR-Cas9 gene-editing system for therapeutic applications
    Liu, Chang
    Zhang, Li
    Liu, Hao
    Cheng, Kun
    JOURNAL OF CONTROLLED RELEASE, 2017, 266 : 17 - 26
  • [49] Delivery and Specificity of CRISPR/Cas9 Genome Editing Technologies for Human Gene Therapy
    Gori, Jennifer L.
    Hsu, Patrick D.
    Maeder, Morgan L.
    Shen, Shen
    Welstead, G. Grant
    Bumcrot, David
    HUMAN GENE THERAPY, 2015, 26 (07) : 443 - 451
  • [50] Establishment of a CRISPR/Cas9 gene-editing system for Chrysanthemum morifolium
    Chen, Qi
    Zhang, Xin
    Jin, Ruibing
    Mao, Hongyu
    ORNAMENTAL PLANT RESEARCH, 2024, 4